A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

NCT03845400 · clinicaltrials.gov ↗
COMPLETED
Status
168
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Shire

Collaborators